Cowen and Company’s Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 ANAC.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-101,675
Closed -$4.3K 782
2022
Q4
$4.3K Sell
101,675
-300
-0.3% -$13 ﹤0.01% 507
2022
Q3
$6K Buy
101,975
+1,975
+2% +$209 ﹤0.01% 494
2022
Q2
$12K Sell
100,000
-2,171
-2% -$530 ﹤0.01% 460
2022
Q1
$35K Buy
+102,171
New +$49.7K ﹤0.01% 372

Cowen and Company's ANAC.WS Position: Q1 2023 in Review

Cowen and Company sold out of Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (ANAC.WS) in Q1 2023, closing a stake of 101,675 shares — an estimated $4.3K sold.

Cowen and Company first reported a position in ANAC.WS in Q1 2022 and held it in 4 quarters. The position peaked at $35K in Q1 2022. 0 funds tracked by Wall St. Rank hold ANAC.WS as of Q1 2023.

  • Cowen and Company reported no remaining Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q1 2023 after selling out during the quarter.
  • Cowen and Company sold 101,675 Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q1 2023, an estimated $4.3K.
  • Cowen and Company first reported a position in Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 4 quarters.
  • Cowen and Company's Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $35K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Arctos NorthStar Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q1 2023.

Based on Cowen and Company's 13F filing for Q1 2023, filed 9 May 2023.